Skip to main content

Table 1 Baseline characteristics of normokalemic (control) and hyperkalemic patients

From: ECG alterations suggestive of hyperkalemia in normokalemic versus hyperkalemic patients

  Age (years)   Female Prior CKD Prior RRT Death within 72 h need of RRT HF DM HT Liver failure Sepsis Malignancy Dehydration B-blocker Digitalis ACEi ARB Spironolactone Amilorid NSAID K suppl
Kontroll (n = 170) 60.45 ± 15.95 % 54,7% 8,8% 1,2% 2,4% 0,0% 11,8% 20,6% 64,1% 4,1% 1,2% 14,1% 10,0% 38,8% 4,1% 37,6% 10,6% 4,7% 1,2% 8,2% 15,3%
n 93 15 2 4 0 20 35 109 7 2 24 17 66 7 64 18 8 2 14 26
Hyper-kalemia (n = 135) 70.61 ± 13.93 % 51,9% 29,6%* 7,4%* 13,3%* 15,6%* 32,6%* 36,3%* 73,3% 11,1%* 14,8%* 29,6%* 31,1%* 45,9%* 5,9% 54,8%* 14,1%* 15,6%* 14,1%* 16,3%* 35,6%*
n 70 40 10 18 21 44 49 99 15 20 40 42 62 8 74 19 21 19 22 48
  1. (CKD: chronic kidney disease, RRT renal replacment therapy, HF: heart failure, DM: diabetes mellitus, HT: hypertension, K suppl: potassium supplementation, *: p ≤ 0,05)